Connect with us

Press Releases

B+L Ultra Contacts Get FDA OK for Extended Wear




(PRESS RELEASE) LAVAL, QUEBEC — Bausch + Lomb, a subsidiary of Valeant Pharmaceuticals International, announced that the U.S. Food and Drug Administration has approved the Bausch + Lomb ULTRA family of contact lenses for extended wear of up to six nights and seven days of continuous wear. First introduced in the U.S. in 2014, Bausch + Lomb ULTRA is the only brand of contact lenses that include MoistureSeal technology, a patented combination of material and manufacturing process, which helps to maintain 95 percent of lens moisture for a full 16 hours.

“Developed in-house by our team of scientists and lens designers, Bausch + Lomb ULTRA lenses help address the needs of today’s contact lens patients,” said Joseph C. Papa, chairman and CEO, Valeant. “Bausch + Lomb ULTRA lenses offer an exceptional lens wearing experience, backed by outstanding clinical performance, and now, convenient, continuous wear for up to six nights and seven days.”

Bausch + Lomb ULTRA contact lenses are engineered to provide all-day comfort and consistently clear vision. The family of contact lenses features polyvinylpyrrolidone (PVP) for enhanced wettability, a high oxygen transmissibility level (Dk/t) (i.e. ability of the lens to let oxygen reach the eye), and a low modulus (i.e. the degree of a contact lens material’s flexibility or its resistance to being deformed). Bausch + Lomb ULTRA contact lenses are also available for patients with astigmatism and presbyopia. 

“Bausch + Lomb ULTRA contact lenses are a trusted and preferred lens option for my practice and my patients,” said Ben Gaddie, OD, Gaddie Eye Centers, Louisville, KY. “Now with the extended wear indication, I can offer these lenses to patients who prefer a longer wearing schedule as part of their lifestyle.”


For more information on Bausch + Lomb ULTRA contact lenses, visit

Important Safety Information about Bausch + Lomb ULTRA Contact Lenses (Extended Wear)    

The risk of microbial keratitis and other potentially vision-threatening adverse events has been shown to be greater among users of extended wear contact lenses than among users of daily wear contact lenses. If a patient experiences eye discomfort, excessive tearing, vision changes, or redness of the eye, the patient should be instructed to immediately remove the lenses and promptly contact his or her eye care practitioner.




With Topcon RDx® Now You Can

Introducing Topcon RDx®, a comprehensive eye health exam platform that incorporates automated and remote capabilities for your diagnostic instruments. Grow your practice beyond your physical location and deliver quality eye exams from virtually anywhere.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.


Most Popular